Sales & Marketing Changing Faces – Board of Directors and Advisory Boards – Ap... April was a busy month for Boards, with a number of biotechs appointing new Chairs, as well as plenty of other Board seat changes.
Sales & Marketing Changing Faces – Agency, consultancy, and investor hires – A... Stay up-to-date with the agency, consultancy, and investor hires from April.
Digital Changing Faces – Digital and supplier hires – April 2025 We saw a range of hires in April in pharma-adjacent sectors like manufacturing and clinical research.
R&D Changing Faces – Pharma and biotech hires – April 2025 April saw quite a bit of movement in the biotech C-Suites, including both departures and arrivals. Read on for a whirlwind, worldwide tour of recent personnel moves.
News UnitedHealth CEO Andrew Witty steps down Andrew Witty has resigned as CEO of US health conglomerate UnitedHealth, as the company pulled its financial forecasts for 2025.
News Galapagos drops plan to split after 'market developments' Shortly after announcing a plan to separate its drug and cell therapy businesses into two separate companies, Galapagos has had a change of heart.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.